Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Impact of Donor Type on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Blood (2024) 144 (Supplement 1): 3559.

https://doi.org/10.1182/blood-2024-193992

Published: 2024

Journal Articles

Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques

Blood (2024) 144 (Supplement 1): 3558.

https://doi.org/10.1182/blood-2024-200237

Published: 2024

Journal Articles

Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study

Blood (2024) 144 (Supplement 1): 4797.

https://doi.org/10.1182/blood-2024-207660

Published: 2024

Journal Articles

Decreased Chronic GvHD with Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelofibrosis Allografted with Unrelated Donor: A Study from the Chronic Malignancies Working Party of the EBMT

Blood (2024) 144 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2024-203487

Published: 2024

Journal Articles

Methodology and Clinical Significance of Longitudinal UBA1 Clonal Burden Evaluation in Vexas Syndrome

Blood (2024) 144 (Supplement 1): 2690.

https://doi.org/10.1182/blood-2024-194413

Published: 2024

Journal Articles

No Differences in Transplant Outcomes with Post-Transplant Cyclophosphamide in One Antigen Mismatched Unrelated Donor Compared to Matched Unrelated Donor Recipients Receiving Antithymocyte Globulin in Patients with Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Blood (2024) 144 (Supplement 1): 693.

https://doi.org/10.1182/blood-2024-203472

Published: 2024

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Haploidentical Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Blood (2024) 144 (Supplement 1): 4944.

https://doi.org/10.1182/blood-2024-207391

Published: 2024

Journal Articles

Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT

Blood (2022) 140 (Supplement 1): 4870–4871.

https://doi.org/10.1182/blood-2022-166081

Published: 2022

Journal Articles

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Blood (2021) 138 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2021-152907

Published: 2021

Journal Articles

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137099

Published: 2020

Journal Articles

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Florent Malard, MD PhD, Giorgia Battipaglia, MD, Béatrice Gaugler, PhD, Rémy Duléry, MD, Eolia Brissot, MD PhD, Tounes Ledraa, MD, Razan Mohty, MD, Harry Sokol, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 194.

https://doi.org/10.1182/blood-2019-122256

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 148.

https://doi.org/10.1182/blood-2019-123269

Published: 2019

Journal Articles

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Razan Mohty, MD, Remy Dulery, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Simona Sestili, MD, Tounes Ledraa, MD, Béatrice Gaugler, PhD, Agnès Bonnin, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2019) 134 (Supplement_1): 4539.

https://doi.org/10.1182/blood-2019-125213

Published: 2019

Journal Articles

Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients

Nicola Polverelli, Paolo Tura, Giorgia Battipaglia, MD, Gandolfi Lisa, Tatiana Zollner, MD, Michele Malagola, MD, Enrico Morello, MD, Alessandro Turra, MD, Simona Bernardi, PhD, Camilla Zanaglio, PhD, Federica Re, Mohamad Mohty, MD PhD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 41.

https://doi.org/10.1182/blood-2019-127026

Published: 2019

Journal Articles

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Rémy Duléry, MD, Laure Lebras, MD, Sylvain Choquet, MD, Roberta Di Blasi, Ahmad Kanj AL Jijakli, Laurence Heuberger, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Florent Malard, MD PhD, Clemence Mediavilla, MD, Anne Vekhoff, MD, Paul Coppo, MD PhD, Tounes Ledraa, MD, Zora Marjanovic, Elise Corre, MD, Simona Lapusan, MD, Malek Aoudjhane, MD, Ramdane Belhocine, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 786.

https://doi.org/10.1182/blood-2019-130651

Published: 2019

Journal Articles

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Giorgia Battipaglia, Myriam Labopin, Nicolaus Kröger, Antonin Vitek, Boris Afanasyev, Inken Hilgendorf, Johannes Schetelig, Arnold Ganser, Didier Blaise, Maija Itälä-Remes, Jakob R. Passweg, Francesca Bonifazi, Jurgen Finke, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty

Blood (2019) 134 (11): 892–899.

https://doi.org/10.1182/blood.2019000487

Published: 2019

Includes: Supplemental data

Journal Articles

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

Nicolas Stocker, MD, Remy Duléry, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 4565.

https://doi.org/10.1182/blood-2018-99-111406

Published: 2018

Journal Articles

Post-Transplant Sorafenib Improves Overall Survival in FLT3 Mutated AML: A Report from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD PhD, Myriam Labopin, MD, Giorgia Battipaglia, MD, Azedine Djabali, Edouard Forcade, MD, William Arcese, Gérard Socié, MDPhD, Didier Blaise, Jakob R. Passweg, MDMS, Jan J Cornelissen, MD PhD, Patrice Chevallier, MD, Johan Maertens, MD, Nicolaas Schaap, MD PhD, Khowla Hashaishi, MD, Jean Elcheikh, MD, Florent Malard, MDPhD, Jordi Esteve, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 708.

https://doi.org/10.1182/blood-2018-99-114044

Published: 2018

Journal Articles

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Nicolas Stocker, MD, Agathe Farge, MD, Laure Ricard, MD, Vincent Jachiet, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Remy Duléry, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Béatrice Gaugler, PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 3398.

https://doi.org/10.1182/blood-2018-99-111449

Published: 2018

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from One Antigen HLA-Mismatched Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Giorgia Battipaglia, MD, Myriam Labopin, MD, Kroger Nicolaus, MDPhD, Antonin Vitek, MD, Boris Afanasiev, MD, Inken Hilgendorf, MD, Johannes Schetelig, MD, Arnold Ganser, MD, Didier Blaise, Maija Itälä-Remes, MD PhD, Jakob R. Passweg, MD PhD, Francesca Bonifazi, Jürgen Finke, MD, Annalisa Ruggeri, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 1016.

https://doi.org/10.1182/blood-2018-99-113424

Published: 2018

NARROW

Impact of Donor Type on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques

Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study

Decreased Chronic GvHD with Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelofibrosis Allografted with Unrelated Donor: A Study from the Chronic Malignancies Working Party of the EBMT

Methodology and Clinical Significance of Longitudinal UBA1 Clonal Burden Evaluation in Vexas Syndrome

No Differences in Transplant Outcomes with Post-Transplant Cyclophosphamide in One Antigen Mismatched Unrelated Donor Compared to Matched Unrelated Donor Recipients Receiving Antithymocyte Globulin in Patients with Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Haploidentical Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

Post-Transplant Sorafenib Improves Overall Survival in FLT3 Mutated AML: A Report from the EBMT Acute Leukemia Working Party

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from One Antigen HLA-Mismatched Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only